Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study
- 1 January 1993
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 33 (1) , 45-48
- https://doi.org/10.1016/0006-3223(93)90277-k
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neuroleptic malignant syndrome: A study of CSF monoamine metabolismBiological Psychiatry, 1990
- Neuroleptic Malignant SyndromeArchives of internal medicine (1960), 1989
- Neuroleptic malignant syndromeAmerican Journal of Psychiatry, 1985
- Dantrolen in der Behandlung lebensbedrohlicher psychiatrischer Krankheitsbilder: Ein Beitrag zur Therapie des malignen neuroleptischen Syndroms und der akuten febrilen KatatonieDeutsche Medizinische Wochenschrift (1946), 1985
- Neuroleptic Malignant Syndrome: Response to Dantrolene SodiumAnnals of Internal Medicine, 1983
- Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case reportAmerican Journal of Psychiatry, 1982
- Neuroleptic Malignant Syndrome-like State Following a Withdrawal of Antiparkinsonian DrugsJournal of Nervous & Mental Disease, 1981
- Neuroleptic malignant syndromeNeurology, 1981
- I. Liquid chromatography with pre-column sample enrichment and electrochemical detection. Regional determination of serotonin and 5-hydroxyindoleacetic acid in brain tissueLife Sciences, 1980
- Determination of homovanillic acid in urine by liquid chromatography with electrochemical detectionAnalytical Chemistry, 1976